Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.


Player Avatar tenmiles (99.46) Submitted: 8/22/2008 10:03:29 AM : Underperform Start Price: $20.26 VRX Score: +7.66

Technically ripe for 10-15% retracement from current $20.32 level; fundies aren't so hot either - seller here

Member Avatar andrewassur (< 20) Submitted: 4/11/2014 9:17:56 PM
Recs: 0

I would say incorrect evaluation

Featured Broker Partners